1. Home
  2. OGN vs BCAT Comparison

OGN vs BCAT Comparison

Compare OGN & BCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$13.75

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo BlackRock Capital Allocation Term Trust of Beneficial Interest

BCAT

BlackRock Capital Allocation Term Trust of Beneficial Interest

HOLD

Current Price

$15.88

Market Cap

1.7B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
OGN
BCAT
Founded
1923
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.7B
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
OGN
BCAT
Price
$13.75
$15.88
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$11.40
N/A
AVG Volume (30 Days)
2.6M
638.0K
Earning Date
05-07-2026
01-01-0001
Dividend Yield
0.60%
9.38%
EPS Growth
N/A
N/A
EPS
0.95
N/A
Revenue
$6,216,000,000.00
N/A
Revenue This Year
$0.45
N/A
Revenue Next Year
$1.67
N/A
P/E Ratio
$14.47
$11.22
Revenue Growth
N/A
N/A
52 Week Low
$5.69
$13.73
52 Week High
$13.76
$16.20

Technical Indicators

Market Signals
Indicator
OGN
BCAT
Relative Strength Index (RSI) 72.40 50.65
Support Level $13.46 $15.55
Resistance Level N/A $15.97
Average True Range (ATR) 0.04 0.15
MACD 0.00 -0.02
Stochastic Oscillator 93.18 36.36

Price Performance

Historical Comparison
OGN
BCAT

About OGN Organon & Co.

Organon & Cois a globalised healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day. Its operations include the following product portfolios: Women's Health: Itbwomen's health portfolio of products is sold by prescription mainly in two therapeutic areas: contraception, with key brands such as Nexplanon, and fertility, with key brands such as Follistim. other women's health products include the Jada, which is intended to provide control and treatment of abnormal postpartum uterine bleeding or hemorrhage when conservative management is warranted. The General Medicines portfolio includes biosimilars and established brands. Companies' current biosimilars portfolio spans across immunology and oncology-related treatments.

About BCAT BlackRock Capital Allocation Term Trust of Beneficial Interest

BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.

Share on Social Networks: